Results 231 to 240 of about 9,974,913 (281)
Some of the next articles are maybe not open access.

Drug Interactions in Anesthesia

Current Opinion in Anaesthesiology, 1997
Anaesthesia is nowadays seldom accomplished by a single agent because no single agent is able to provide all components of anaesthesia without seriously compromising haemodynamic and/or respiratory function, reducing operating conditions, or postponing postoperative recovery.
openaire   +4 more sources

Pharmacodynamic Drug–Drug Interactions

Drug Discovery and Evaluation: Methods in Clinical Pharmacology, 2020
Mingwu Zheng
semanticscholar   +1 more source

Drug-Drug Interactions with Antipsychotics

CNS Spectrums, 2007
Recognizing drug-drug interactions (DDIs) has become increasingly important as the country's demographics have aged, resulting in more complex medication regimens. Budnitz and colleagues highlighted the frequency of adverse drug reactions (ADRs) and the substantial morbidity that results.
openaire   +3 more sources

Drug-Drug Interaction

JAMA: The Journal of the American Medical Association, 1969
Interference With the Delivery of Drugs to Their Sites of Action An increasing number of mechanisms have been described whereby one drug can modify profoundly the action of another. In some of these interactions, the therapeutic effect of a drug may be blocked when another agent prevents it from reaching the site of its pharmacologic action ...
openaire   +2 more sources

Drug‐Drug Interactions With Fluoroquinolones

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1993
Antimicrobials of the fluoroquinolone class are involved in a number of clinically important drug‐drug interactions. Many of these interactions occur with all the available agents and exhibit little interpatient variability. In contrast, others occur only with specific fluoroquinolones and their extent varies markedly among subjects.
openaire   +3 more sources

Onconephrology: The intersections between the kidney and cancer

Ca-A Cancer Journal for Clinicians, 2021
Mitchell H Rosner   +2 more
exaly  

Drug-Drug Interactions

2004
FDA evidence standards for demonstrating the effectiveness and safety of a new molecular entity (NME) are well evolved and defined by current laws and regulations. However, because only a limited number of patients can be studied during the drug development process, unpredictable adverse events can occur following approval. While serious post-marketing
openaire   +2 more sources

Cocaine Drug-Drug Interactions

Journal of Clinical Psychopharmacology, 1992
Domenic A. Ciraulo, Brian F. Sands
openaire   +3 more sources

Home - About - Disclaimer - Privacy